Latest news
- RxSight, Inc. Announces Pricing of Initial Public Offering
04:16 - GlobeNewswire - S. Korea: 1.3M Moderna jab doses due next week
03:38 - TeleTrader - Williams Rowland Acquisition Corp. Announces Closing of $200 Million Initial Public Offering
03:18 - GlobeNewswire - Junshi Biosciences Announces Acceptance by NMPA of Supplemental New Drug Application for Toripalimab Plus Chemotherapy as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma
02:40 - GlobeNewswire - iSIGN Media Announces a Proposed Private Placement of up to $1.2 million
02:30 - GlobeNewswire
Real-time